27-hydroxycholesterol has been researched along with felodipine in 1 studies
Studies (27-hydroxycholesterol) | Trials (27-hydroxycholesterol) | Recent Studies (post-2010) (27-hydroxycholesterol) | Studies (felodipine) | Trials (felodipine) | Recent Studies (post-2010) (felodipine) |
---|---|---|---|---|---|
345 | 11 | 214 | 1,328 | 421 | 238 |
Protein | Taxonomy | 27-hydroxycholesterol (IC50) | felodipine (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 1.057 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 4.5795 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.057 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.057 | |
Bile acid receptor | Homo sapiens (human) | 4.96 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lam, M; Mast, N; Pikuleva, IA | 1 |
1 other study(ies) available for 27-hydroxycholesterol and felodipine
Article | Year |
---|---|
Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo.
Topics: Animals; Antihypertensive Agents; Cholestanetriol 26-Monooxygenase; Cytochrome P-450 Enzyme Inhibitors; Drug Discovery; Drug Evaluation, Preclinical; Felodipine; Female; Hydroxycholesterols; Mice, Inbred C57BL | 2018 |